PVP-Citric Acid Copolymer Wound Dressing for Biofilm Disruption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current wound dressings fail to effectively prevent, reduce, or disrupt biofilm formation in wounds, which can impede healing and lead to infections, tissue loss, and systemic issues.
Innovation Solution
A wound dressing composition incorporating a hydrogel with a co-polymer of polyvinylpyrrolidone (PVP) and citric acid, combined with a mixture of collagen and oxidized regenerated cellulose (ORC), designed to disrupt biofilm formation and promote wound healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional wound dressings are used, then basic wound care is provided, but biofilm formation is not effectively prevented or disrupted
Solution Approach 1:
The patent employs a composite hydrogel system integrating multiple functional components: PVP-citric acid copolymer for biofilm disruption, collagen for tissue regeneration support, and oxidized regenerated cellulose for absorption. This composite approach achieves reliable biofilm prevention while maintaining manageable complexity through synergistic material interactions.
Solution Approach 2:
The invention modifies the chemical composition parameters of the hydrogel by incorporating specific ratios of PVP-citric acid copolymer, collagen, and oxidized regenerated cellulose. These parameter changes enable the dressing to simultaneously achieve biofilm disruption capability and tissue compatibility without excessive complexity.
2Reliability
If a multi-component hydrogel system is used to disrupt biofilm, then biofilm prevention is improved, but manufacturing complexity increases
Solution Approach 1:
The patent merges multiple functional ingredients into a single integrated hydrogel dressing formulation. The PVP-citric acid copolymer, collagen, and oxidized regenerated cellulose are combined in one cohesive product, improving biofilm disruption capability while simplifying manufacturing by eliminating the need for separate application steps.
Solution Approach 2:
The hydrogel dressing is designed with multi-functionality: the PVP-citric acid copolymer component provides biofilm disruption, collagen supports tissue regeneration, and oxidized regenerated cellulose offers absorption capabilities. This universal design achieves multiple therapeutic goals in a single product, balancing enhanced effectiveness with manufacturing efficiency.
3Reliability
If active agents are added to PVP hydrogel to inhibit microorganisms, then antimicrobial effectiveness is improved, but product complexity increases
Solution Approach 1:
The patent converts the potential harm of complex formulation into benefit by systematically integrating multiple active components with defined functions. The PVP-citric acid copolymer, collagen, and oxidized regenerated cellulose are combined in proportions that create synergistic effects, transforming formulation complexity into enhanced microorganism inhibition effectiveness while maintaining product manageability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dressing effectively reduces biofilm levels by inhibiting bacterial colonization, thereby enhancing wound healing and reducing the risk of infections, with the co-polymer and ORC components working synergistically to create an environment conducive to tissue repair.
Implementation Method 1
the addition of active agents makes it suitable to inhibit gram negative microorganisms and gram-positive microorganism
Implementation Method 2
a second layer that includes a mixture of a collagen and an oxidized regenerated cellulose (ORC)
Implementation Method 3
a second layer that includes a mixture of a collagen and an oxidized regenerated cellulose (ORC)
Data Source
AI summary
Dressings which may be useful in disrupting and/or preventing biofilm formation in a wound upon application are described, where the dressings of the present technology include a co-polymer of polyvinylpyrrolidone (PVP) and citric acid. Also disclosed herein methods employing such dressings as well as kits including such dressings.